期刊文献+

川崎病合并重症感染患儿的预后分析 被引量:7

Analysis on the children with Kawasaki disease combined with severe infection
原文传递
导出
摘要 目的:探讨重症感染与川崎病(KD)预后的关系。方法:选自2005年5月~2010年5月于该院儿科诊治的、发热7天以内的KD患儿,共271例,均符合第3届国际川崎病会议修订的诊断标准。将271例KD患儿分为重症感染组和非重症感染组〔参照小儿危重症评分法(草案)〕。重症感染组73例,包括重症肺炎44例(其中17例患儿血清肺炎支原体IgM滴度≥1∶160),病毒性脑炎20例,败血症9例。非重症感染组198例。结果:重症感染组年龄<1岁的人数与非重症感染组间差别有统计学意义(P<0.05),但两组之间性别为男性的差别无统计学意义(P>0.05);重症感染组血小板<350×109/L、血沉>60 mm/h,C-反应蛋白>45 mg/L人数明显高于非重症感染组(P<0.05);而红细胞压积<0.35、血清清蛋白<35 g/L两组比较差异无统计学意义(P>0.05)。应用丙种球蛋白(IVIG)治疗36 h后,重症感染组热退例数少于非重症感染组(χ2=13.155,P<0.05);1个月内存在冠状动脉(冠脉)扩张者两组间差异无统计学意义(χ2=2.450,P>0.05);6个月后残留冠脉扩张者,重症感染组高于非重症感染组(χ2=4.595,P<0.05)。结论:①重症感染患儿其冠脉病变危险因素的几率较高,提示重症感染可作为KD预后不良的早期指标之一。②KD合并重症感染患儿对IVIG治疗反应较差,并易发生冠脉扩张。因此,对KD合并重症感染患儿应提高认识,及早治疗,警惕其发生冠脉病变。 Objective: To explore the relationship between severe infection and prognosis of Kawasaki disease. Methods: A total of 271 children with Kawasaki disease who were diagnosed and treated in pediatric department of the hospital and got fever within seven days from May 2005 to May 2010 were selected, and all the children conformed to the diagnostic criteria revised on the Third International Ka- wasaki Disease Symposium. All the children were divided into severe infection group (73 children) and non -severe infection group (198 children) according to the score of children with critical illness (preliminary draft) . Forty -four children with severe pneumonia (including 17 children with serum Mycoplasma pneumoniae IgM titer≥1: 160), 20 children with viral encephalitis, and 9 children with sepsis were included into severe infection group. Results : There was significant difference in the number of children under one year old between severe infection group and non -severe infection group (P 〈 0. 05 ), but there was no significant difference in the number of boys between the two groups ( P 〉 0.05 ) . The numbers of children with platelet 〈 350 x 109/L, erythroeyte sedimentation rate 〉 60 ram/h, and C - reactive protein 〉 45 mg/L in severe infection group were significantly higher than those in non -severe infection group (P 〈 0. 05 ) ; there was no significant difference in the numbers of children with hematoerit 〈 0. 35 and serum albumin 〈 35 g/L between the two groups (P 〉 0. 05 ) . After treating the children with gamma globulin for 36 hours, the number of children with pyretolysis in severe infection group was less than that in non - severe infection group (χ2 = 13. 155, P 〈 0. 05 ) . There was no significant difference in the number of children with coronary arterieetasis within one month between the two groups (χ2 = 2. 450, P 〉 0. 05 ) ; the number of children with coronary arteriectasis within six months in severe infection group was significantly higher than that in non - severe infection group (χ2 = 4. 595, P 〈 0. 05 ) . Conclusion: The chil- dren with severe infection have high probability of coronary artery lesions, which indicates that severe infection can be used as an early indicator of poor prognosis of Kawasaki disease. The reaction of children with Kawasaki disease combined with severe infection to gamma globulin therapy is poor, and the children are prone to combine with coronary arteriectasis. Thus, the children with Kawasaki disease combined with severe infection should be diagnosed and treated early, more attention should be paid to coronary artery lesions.
出处 《中国妇幼保健》 CAS 北大核心 2012年第2期209-211,共3页 Maternal and Child Health Care of China
关键词 川崎病 重症感染 冠状动脉扩张 预后 Kawasaki disease Severe infection Coronary arteriectasis Prognosis
  • 相关文献

参考文献11

  • 1Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid in- volvement with specific desquamation of the dangers and toes in children (in Japanese) . Jpn [J] . Allerg, 2007, 16:178 -222.
  • 2Takeshita S, Tsujimoto H, Nakatani K. Intravenou simmunoglobulin preparations promote apoptosis in lipopolysaccharide- stimulated neu- trophils via an oxygen - dependent pathway in vitro[J] . APMIS, 2005:35-37.
  • 3Newburger JW, Taubert KA, Shulman ST et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium : December 4 -7, 2001, Hakone, Japan [J] . Pediatrics, 2003, 53 (1): 153- 157.
  • 4中华急诊医学会儿科学会急救学组.第4届全国小儿急救医学研讨会纪要[J].中华儿科杂志,1995,33:371-371.
  • 5Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvemet with specific desquamation of the fingers and toes in children (Japanese) [J] . Japan J Allergy, 1967, 16:178 - 122.
  • 6Silva AA, Maeno Y, Hashmi A et al. Cardiovascular risk factors after Kawasaki disease: a case- control study [J]. J Pediatr, 2001, 138 (3) : 400 - 405.
  • 7Catalano - Ports C, Quarrier P, Lemez - ViUe Met al. Primary cyto megalovious infection, atypical Kawasaki disease, and coronary artery aneurysms in 2 infants[J]. Clin Infect Dis, 2005, 41 (5) : e53 - e56.
  • 8Ieung DY, Meisrner HC, Shulman ST et al. Prevalence of superantigen -secreting bacteria in patients with Kawasaki disease[J] . J Pediatr, 2002, 140 (6): 742-746.
  • 9Reunanen A, Roivainen M, Kleemola Met al. Enterovirus, mycoplasma and other infections as predictors for myocardial infarction [J]. J Intern Med, 2002, 252 (5): 421 -429.
  • 10Sessa R, Pietro M, Schiavoni G et al. Detection of chlamydia pneumon- iae in atherosclerotic coronary arteries [J] . Int J Immunopathol Phar macol, 2004, 17 (3): 301-306.

共引文献51

同被引文献70

  • 1王琍,林毅,苏英姿,汪芸,赵地,吴铁吉.283例川崎病的临床分析[J].中华儿科杂志,2004,42(8):609-612. 被引量:84
  • 2杜忠东,梁璐,孟晓萍,李棠,张拓红,川崎富作,柳川洋,北京小儿川崎病流行病学调查协作组.1995~1999年北京住院小儿川崎病流行病学调查[J].中华医学杂志,2003,83(21):1874-1878. 被引量:25
  • 3张伟,李秋,赵晓东,唐雪梅,王晓刚,王墨,吴道奇,欧茜,杨锡强.川崎病发生冠状动脉病变危险因素的Logistic回归分析[J].中国实用儿科杂志,2006,21(1):51-53. 被引量:40
  • 4胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 5Eto Y.Genome research in pediatric field[J].Nihon Rinsho, 2009, 67(6): 1146-1155.
  • 6无,赵晓东(整理),杜忠东(整理).川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830. 被引量:149
  • 7Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treat- ment, and long-term management of Kawasaki disease : a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis,and Kawasaki Disease, Council on Cardiovascular Disease in the Young ,American Heart Association[J]. Pediatrics, 2004,114(6) : 1708-1733.
  • 8Rowley AH. Incomplete (atypical) Kawasaki disease[J]. Pediatr Infect Dis,2002,21 (6) :563-565.
  • 9Takeshita S, Tsujimoto H, Nakatani K. Intravenous immunoglob- ulin preparations promote apoptosis in lipopolysaccharide-stimu- lated neutrophils via an oxygen-dependent pathway in vitro [J]. APMIS, 2005,113 (4) : 269-277.
  • 10JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki dis- ease (JCS 2013) . Digest version. Circ J, 2014, 78 (10) : 2521-2562.

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部